First, what compounding means
Compounding means making a medicine to order rather than supplying a finished drug from its maker.
As of September 2026, compounded medicines are not FDA approved; the agency does not review quality, benefits or harms before these medicines are marketed.
Compounding can meet a medical need, but its use is subject to legal conditions.
Ordinary pharmacies: what ingredients can they use?
A raw ingredient needs to qualify in at least one of three ways for ordinary pharmacy compounding. As of October 1, 2026, ipamorelin qualifies in none of them.
There is no official quality standard for either form of ipamorelin. This means an official written standard for checking the ingredient, not a failed laboratory test.
Neither form is part of a drug approved by the FDA. Neither is on the official list of extra ingredients these pharmacies may use.
Before paying, ask the pharmacy which legal condition would allow it to use the ingredient. A pharmacy licence alone does not answer that.
Businesses that make batches for clinics and hospitals
These businesses are called outsourcing facilities, or 503B facilities after the section of the law. They make batches of medicines without needing a prescription for each named patient.
As of October 1, 2026, ipamorelin is absent from the larger facilities’ allowed list.
Ipamorelin acetate, the salt form and another chemical form of ipamorelin, also remains in their FDA safety-concern group, called Category 2.